Literature DB >> 16314418

Regulation of p53 by activated protein kinase C-delta during nitric oxide-induced dopaminergic cell death.

Sung-Jin Lee1, Dong-Chan Kim, Bo-Hwa Choi, Hyunjung Ha, Kyong-Tai Kim.   

Abstract

Selective cell death of dopaminergic neurons in the substantia nigra is the major cause of Parkinson disease. Current evidence suggests that this cell death could be mediated by nitric oxide by-products such as nitrate and peroxynitrite. Because protein kinase C (PKC)-delta is implicated in apoptosis of various cell types, we studied its roles and activation mechanisms in nitric oxide (NO)-induced apoptosis of SN4741 dopaminergic cells. When cells were treated with sodium nitroprusside (SNP), a NO donor, endogenous PKC-delta was nitrated and activated. Immunoprecipitation revealed that p53 co-immunoprecipitated with PKC-delta and was phosphorylated at the 15th serine residue in SNP-treated cells. An in vitro kinase assay revealed that p53 was directly phosphorylated by SNP-activated PKC-delta. The p53 Ser-15 phosphorylation was suppressed in SNP-treated cells when the NO-mediated activation of PKC-delta was inhibited by rottlerin or (-)-epigallocatechin gallate. Within 3 h of p53 phosphorylation, its protein levels increased because of decreased ubiquitin-dependent proteosomal proteolysis, whereas the protein levels of MDM2, ubiquitin-protein isopeptide ligase, were down-regulated in a p53 phosphorylation-dependent fashion. Taken together, these results demonstrate that nitration-mediated activation of PKC-delta induces the phosphorylation of the Ser-15 residue in p53, which increases its protein stability, thereby contributing to the nitric oxide-mediated apoptosis-like cell death pathway. These findings may be expanded to provide new insight into the cellular mechanisms of Parkinson disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16314418     DOI: 10.1074/jbc.M509509200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Aerobic glycolysis suppresses p53 activity to provide selective protection from apoptosis upon loss of growth signals or inhibition of BCR-Abl.

Authors:  Emily F Mason; Yuxing Zhao; Pankuri Goraksha-Hicks; Jonathan L Coloff; Hugh Gannon; Stephen N Jones; Jeffrey C Rathmell
Journal:  Cancer Res       Date:  2010-09-28       Impact factor: 12.701

Review 2.  Structural basis of protein kinase C isoform function.

Authors:  Susan F Steinberg
Journal:  Physiol Rev       Date:  2008-10       Impact factor: 37.312

3.  Methamphetamine-induced neurotoxicity linked to ubiquitin-proteasome system dysfunction and autophagy-related changes that can be modulated by protein kinase C delta in dopaminergic neuronal cells.

Authors:  M Lin; P Chandramani-Shivalingappa; H Jin; A Ghosh; V Anantharam; S Ali; A G Kanthasamy; A Kanthasamy
Journal:  Neuroscience       Date:  2012-03-14       Impact factor: 3.590

4.  hnRNP Q regulates translation of p53 in normal and stress conditions.

Authors:  D-Y Kim; W Kim; K-H Lee; S-H Kim; H-R Lee; H-J Kim; Y Jung; J-H Choi; K-T Kim
Journal:  Cell Death Differ       Date:  2012-08-31       Impact factor: 15.828

Review 5.  Role of p53 in neurodegenerative diseases.

Authors:  J Robert Chang; Mohammad Ghafouri; Ruma Mukerjee; Asen Bagashev; Tinatin Chabrashvili; Bassel E Sawaya
Journal:  Neurodegener Dis       Date:  2011-10-28       Impact factor: 2.977

6.  PKCdelta regulates cortical radial migration by stabilizing the Cdk5 activator p35.

Authors:  Chun-tao Zhao; Kun Li; Jun-tao Li; Wang Zheng; Xu-jun Liang; An-qi Geng; Ning Li; Xiao-bing Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-24       Impact factor: 11.205

7.  Nitrated alpha-synuclein induces the loss of dopaminergic neurons in the substantia nigra of rats.

Authors:  Zhongwang Yu; Xiaohui Xu; Zhenghua Xiang; Jianfeng Zhou; Zhaohuan Zhang; Chun Hu; Cheng He
Journal:  PLoS One       Date:  2010-04-08       Impact factor: 3.240

8.  p38δ regulates p53 to control p21Cip1 expression in human epidermal keratinocytes.

Authors:  Kamalika Saha; Gautam Adhikary; Santosh R Kanade; Ellen A Rorke; Richard L Eckert
Journal:  J Biol Chem       Date:  2014-03-05       Impact factor: 5.157

Review 9.  Targeting MDM2 for novel molecular therapy: Beyond oncology.

Authors:  Wei Wang; Jiang-Jiang Qin; Mehrdad Rajaei; Xin Li; Xiaoyi Yu; Courtney Hunt; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2019-10-06       Impact factor: 12.944

10.  Oxidized low-density lipoprotein-induced matrix metalloproteinase-9 expression via PKC-delta/p42/p44 MAPK/Elk-1 cascade in brain astrocytes.

Authors:  Hui-Hsin Wang; Hsi-Lung Hsieh; Cheng-Ying Wu; Chuen-Mao Yang
Journal:  Neurotox Res       Date:  2009-06-25       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.